
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ILM1k | Xetra | EUR | Delayed | |
ILM1k | Frankfurt | EUR | Delayed | |
ILM1k | TradeGate | EUR | Delayed | |
ILM1 | Vienna | EUR | Real-time |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.
Name | Age | Since | Title |
---|---|---|---|
Yann Samson | 51 | - | Chairman of Supervisory Board & Sustainability Officer |
Anke Nestler | 55 | 2021 | Deputy Chairwoman of the Supervisory Board |
Joachim Messner | 64 | 2016 | Member of the Supervisory Board |
Florian Herger | 44 | 2024 | Member of the Supervisory Board |
Jens Apermann | 57 | 2024 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review